Quantum-Si appoints biotech executive Amir Jafri to board of directors

Quantum-Si Inc

Amir Jafri appointed to Board, effective September 22, 2023; Board size increased from 8 to 9.
Jafri is founder, President and CEO of Immunicom, a clinical-stage biotech company.
Board determined Jafri is independent under Nasdaq rules; standard non-employee director compensation applies.
John Patrick (Jack) Kenny appointed Chairperson of the Nominating and Corporate Governance Committee.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Amir Jafri

Director

QSI · Quantum-Si Inc

Effective: 2023-09-22
Filed: September 21, 2023, 7:59 PM ET

On September 15, 2023, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Amir Jafri to the Board, effective as of September 22, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Amir Jafri was appointed as Director at Quantum-Si Inc.

Action: appointed
Role: Director

Exact text from the filing

On September 15, 2023, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Amir Jafri to the Board, effective as of September 22, 2023.

View on SEC.gov

Quantum-Si Inc filing history →

Source: SEC EDGAR

accession 0001140361-23-044686

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.